about
Ecological assessment of the direct and indirect effects of routine rotavirus vaccination in Merseyside, UK using data from multiple health systems: a study protocol.Exploring the potential impact of rotavirus vaccination on work absenteeism among female administrative personnel of the City of Antwerp through a retrospective database analysis.Improvement in hospital Quality of Care (QoC) after the introduction of rotavirus vaccination: An evaluation study in Belgium.Medium- to Long-Term Impact of Rotavirus Vaccination on Hospital Care in Belgium: A 7-Year Follow-Up of the Rotavirus Belgium Impact Study (RotaBIS).The Impact of Socio-Economic Determinants on the Vaccination Rates with Rotavirus and Human Papiloma Virus Vaccine.Rotavirus acceleration of type 1 diabetes in non-obese diabetic mice depends on type I interferon signallingTemporal trends in hospitalization for rotavirus gastroenteritis: A nationwide study in Italy, 2005-2012.Epidemiological trends for hospital admissions for acute rotavirus gastroenteritis in Belgium following the introduction of routine rotavirus vaccination and the subsequent switch from lyophilized to liquid formulation of Rotarix™.Population effectiveness of the pentavalent and monovalent rotavirus vaccines: a systematic review and meta-analysis of observational studies.Universal Mass Vaccination Against Rotavirus: Indirect Effects on Rotavirus Infections in Neonates and Unvaccinated Young Infants Not Eligible for Vaccination.In-season and out-of-season variation of rotavirus genotype distribution and age of infection across 12 European countries before the introduction of routine vaccination, 2007/08 to 2012/13.Hospitalisation of children aged 0-59 months with rotavirus gastro-enteritis before the introduction of routine vaccination (Sicily 2003-2012).Hospital-acquired rotavirus and norovirus acute gastroenteritis in a pediatric unit, in 2014-2015.Receiving early information and trusting Swedish child health centre nurses increased parents' willingness to vaccinate against rotavirus infections.Change in incidence of clinic visits for all-cause and rotavirus gastroenteritis in young children following the introduction of universal rotavirus vaccination in Israel.A cross-sectional vaccination coverage study in preschool children attending nurseries-kindergartens: Implications on economic crisis effect.Narrowing of the Diagnostic Gap of Acute Gastroenteritis in Children 0-6 Years of Age Using a Combination of Classical and Molecular Techniques, Delivers Challenges in Syndromic Approach Diagnostics.Potential safety issues and other factors that may affect the introduction and uptake of rotavirus vaccines.The effectiveness of a rotavirus vaccine in preventing hospitalizations and deaths presumably due to acute infectious diarrhea in Brazilian children: a quasi-experimental study.Vaccination refusal. Autonomy and permitted coercion.Secular trends in incidence of acute gastroenteritis in general practice, France, 1991 to 2015.Italian Physicians' Opinions on Rotavirus Vaccine Implementation.3. How comprehensive can we be in the economic assessment of vaccines?Benefit Versus Risk Assessment of Rotavirus Vaccination in France: A Simulation and Modeling Analysis.Updated cost-effectiveness and risk-benefit analysis of two infant rotavirus vaccination strategies in a high-income, low-endemic setting
P2860
Q30872011-EF3C14EA-581A-4EAB-8475-469A87878A31Q35803191-457AC58B-2AE9-4CCE-A57C-A7A6F2D520A1Q36255821-2F4723DB-46F2-4BAD-8BB9-B45472FA414CQ36739996-A4890D9C-6876-43BF-987C-5F8D3C8F46E2Q36763495-B53E3423-9406-4442-AD91-7ED45EE61A08Q37089580-ED44B07F-C266-4A74-8541-4DAF7D3C44A9Q37309229-B3A0BB50-E910-40AB-A792-6D1924D0FFACQ37367123-FE04C28C-6C83-4817-9768-C83DF9EC3D2BQ38623481-EFEEEF8D-F5B0-4BC2-9D21-7791D75A242BQ39367699-7BA5F65D-0779-4984-8ED0-11110ECDFD0BQ40078893-6ED80D44-9511-4698-A034-01CC9DAB887DQ40130386-36236214-4AC2-4E2B-920A-7DA165EA565CQ40184357-ADF0C114-38D3-4747-A591-C2CA4B4DCE9FQ40238206-7DCA8E29-AA06-4802-9586-9E0D35312D03Q40354451-AA9C7431-4C57-4BF9-B86D-5DB84CF5950DQ40565701-15F33CA2-4157-4C5E-8C67-8CFDFF74E250Q40640714-EFE0737B-433F-4C27-9996-52EE90F75032Q40693674-6B48C87A-D0F3-4A58-9A50-12460FEC86C9Q40919777-F1509D65-9BB2-456F-9AB0-CF5CE4E9E6BBQ42029288-A614FC81-4900-450A-B9DB-025F3EB11628Q47159540-5B69EB39-FDB5-42B7-9B42-F6E26CF16641Q47663403-E5DF9875-5566-4F6C-B612-14722832EA22Q54963976-59B22441-42C1-41D1-92E2-7EB1B70CB095Q55348211-E81C5F72-D4B2-46DA-8889-AD099F12CF11Q58756646-3904B10B-DF46-4C31-9BF4-CB5C48FF3285
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Rotavirus vaccination in Europe: drivers and barriers.
@en
type
label
Rotavirus vaccination in Europe: drivers and barriers.
@en
prefLabel
Rotavirus vaccination in Europe: drivers and barriers.
@en
P2093
P1476
Rotavirus vaccination in Europe: drivers and barriers
@en
P2093
P304
P356
10.1016/S1473-3099(14)70035-0
P577
2014-05-01T00:00:00Z